Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation.

Area of Science:

• Epigenetics and Molecular Biology
• Genomics and Gene Regulation

Background:

• Genome-wide DNA methylation mapping is advancing rapidly due to new sequencing technologies.
• Functional studies are limited by the lack of experimental tools for site-specific DNA methylation manipulation.
• Understanding DNA methylation's role in development and disease requires precise experimental control.

Purpose of the Study:

• To develop a novel CRISPR/Cas9-based system for targeted induction of DNA methylation.
• To enable site-specific epigenetic modifications for functional genomic studies.
• To investigate the role of DNA methylation in gene expression regulation.

Main Methods:

• Fusion of CRISPR/Cas9 with DNA methyltransferase 3A (DNMT3A) to create a targeted methylation tool.
• Utilized short guide RNAs (sgRNAs) to direct the CRISPR/Cas9-DNMT3A fusion to specific genomic loci.
• Applied the system to target CpG islands and specific CpG sites in promoters of CDKN2A, ARF, and Cdkn1a genes.

Main Results:

• Successfully induced DNA methylation at targeted CpG dinucleotides, reaching up to 50% of alleles.
• Observed peak DNA methylation levels within 50 bp of the sgRNA binding site and between paired sgRNAs.
• Demonstrated targeted methylation of CpG islands and sites, leading to decreased expression of target genes.

Conclusions:

• The developed CRISPR/Cas9-DNMT3A system provides a powerful tool for site-specific DNA methylation induction.
• This technology facilitates mechanistic studies of DNA methylation's functional consequences in biological processes.
• Enables deeper understanding of DNA methylation's role in cellular fate determination and disease pathogenesis.